Groupama Asset Managment »

Halozyme Therapeutics shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2023-12-31 $648k 750k 0.86